AreasFocus, starting, and ADHDMedication and how it works

Five minutesAny ordinary dayMedical and treatmentFocus, starting, and ADHD

People usually stop for one of three reasons: the side effects are not worth it, the price is too high, or the dose was never raised far enough to do anything. The last one is the saddest, because it makes a workable medicine look useless.

If a trial ended with the words nothing happened, it is worth going back over what dose was actually reached and for how long it was held there. A dose that was never pushed towards an effect can leave a family convinced that an entire class of medicine failed them, and that belief lasts years. Cost is worth saying out loud too, because there is often a generic or a different formulation at a fraction of the price.

Before you use this

This explains how treatments work. Never start, stop or change a medication because of something you read here.

Qur’an and Sunnah

'Give full measure when you measure, and weigh with accurate scales' (Quran 17:35). Full measure applies to the care someone is given as much as to what is sold to them.

وَأَوۡفُواْ ٱلۡكَيۡلَ إِذَا كِلۡتُمۡ وَزِنُواْ بِٱلۡقِسۡطَاسِ ٱلۡمُسۡتَقِيمِۚ ذَٰلِكَ خَيۡرࣱ وَأَحۡسَنُ تَأۡوِيلࣰ ا

Give full measure when you measure, and weigh with accurate scales: that is better and fairer in the end

Qur’an 17:35read it in the library

Translation: M.A.S. Abdel Haleem, The Qur'an, Oxford University Press, 2004.

What the research says

Dose matters more than people expect. A review of medications for adults found that effect sizes for stimulants approach those seen in school aged children when adequate doses are used, with atomoxetine and bupropion as second line options. On the money, a systematic review of economic evaluations generally found these medicines cost effective, while noting wide variation in the assumptions those models rest on.

Santosh PJ, Sattar S, Canagaratnam M. (2011). Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.. CNS drugs doi

Wu EQ, Hodgkins P, Ben-Hamadi R, Setyawan J, Xie J, Sikirica V, Du EX, Yan SY, Erder MH. (2012). Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.. CNS drugs doi

Strength of evidence: one line of research. A single study, or a theoretical account.

Why it works

A dose too small to do anything gives you all the inconvenience of treatment and none of the benefit.

This one is still a draft. It is waiting on a scholar and a clinician to read it before it is published.

Near this one

More on focus, starting, and adhd

People usually stop for one of three reasons: the side effects are not worth it, the price is too high, or the dose was never raised far enough to do anything. The last one is the saddest, because it makes a workable medicine look useless · Inshirah